Pharmaceutical compositions comprising hydromorphone and naloxone
US9700508B2 · kind B2 · utility
1Cited by
9References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2011 |
| Grant date | Jul 11, 2017 |
| Priority date | — |
| Expiry date | Aug 12, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/1652
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to prolonged release pharmaceutical dosage forms, the manufacture thereof as well as their use for administration to human beings.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.